BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+31.41%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.98B
AUM Growth
+$3.98B
(+27%)
Cap. Flow
-$512K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
64.68%
Holding
36
New
2
Increased
14
Reduced
6
Closed
1
Top Buys
| 1 |
CRISPR Therapeutics
CRSP
|
$29M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$23.4M |
| 3 |
Nektar Therapeutics
NKTR
|
$21.5M |
| 4 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$20.2M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$13.6M |
Top Sells
| 1 |
Ionis Pharmaceuticals
IONS
|
$82.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$25.5M |
| 3 |
Incyte
INCY
|
$16.2M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$13M |
| 5 |
Gilead Sciences
GILD
|
$12.4M |
Sector Composition
| 1 | Healthcare | 96.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALDR
26
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $37.8M | 0.95% |
2,766,008
| – | – |
|
|
27
CRISPR Therapeutics
CRSP
$4.82B
| $29M | 0.73% |
+810,462
| New | +$29M |
|
28
Scholar Rock
SRRK
$3.3B
| $27.8M | 0.7% |
1,476,839
+196,861
| +15% | +$3.7M |
|
|
ITCI
29
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $26.8M | 0.67% |
2,200,000
| – | – |
|
30
Sangamo Therapeutics
SGMO
$161M
| $25.3M | 0.64% |
2,650,000
+1,300,000
| +96% | +$12.4M |
|
31
Kezar Life Sciences
KZR
$28.5M
| $21.7M | 0.54% |
122,050
+40,207
| +49% | +$7.13M |
|
|
GTHX
32
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $11.2M | 0.28% |
671,925
| – | – |
|
33
Cidara Therapeutics
CDTX
$1.61B
| $6.08M | 0.15% |
114,764
| – | – |
|
34
Novavax
NVAX
$1.2B
| $4.59M | 0.12% |
416,500
| – | – |
|
35
Q32 Bio
QTTB
$20.9M
| $2.53M | 0.06% |
+5,074
| New | +$2.53M |
|
|
36
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-68,156
| Closed | -$25.5M |
|